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Zaaijer2 remains the operation of choice in the treat-
ment of achalasia. Questions remain regarding the most
appropriate surgical approach and the necessity for
inclusion of an antireflux procedure in patients under-
going myotomy.3-6 With the advent of laparoscopic and
P neumatic dilation and surgical myotomy remainstandard management alternatives for improving
esophageal emptying by reducing distal esophageal
resistance in patients with achalasia. The extramucosal
myotomy described by Heller1 and modified by
Purpose: Video-assisted surgical approaches to esophageal achalasia con-
tinue to be explored by many surgeons involved in the management of
this motor disorder. We report our experience with thoracoscopic and
laparoscopic esophagomyotomy to more clearly define the efficacy and
safety of these approaches. Patients: Over 73 months, 58 patients with
achalasia underwent thoracoscopic myotomy (n = 19) alone or laparo-
scopic myotomy (n = 39) with partial fundoplication (anterior = 15; pos-
terior = 24). Mean age was 47.2 years and average length of symptoms
was 60 months. Primary symptoms were as follows: dysphagia, 100%;
pulmonary abnormalities, 22%; weight loss; 47%, and pain, 45%.
Mean esophageal diameter was 6 cm and tortuosity was present in 16%
(9/58) of patients. Prior management consisted of dilation (n = 47), bot-
ulinum toxin injection (n = 8), and prior myotomy (n = 1). Methods: In
the operating room all patients underwent endoscopic examination and
evacuation of retained esophageal contents. The esophagomyotomy was
extended 4 cm superiorly and inferiorly to 1 cm beyond the lower
esophageal sphincter. Thoracoscopic and laparoscopic procedures were
completed in all patients without conversion to an open operation. Mean
operative time was 183 minutes (±58.1) and hospital stay averaged 2.3
days (±0.8). There was no operative mortality. The 1 operative compli-
cation was a perforation that was identified during the operation and
repaired thoracoscopically. Results: Symptoms improved in 97% of
patients. Mean dysphagia scores (range 0-10) decreased from 9.8 ± 1.6
before the operation to 2.0 ± 1.5 after the operation (P < .001) at a mean
follow-up of 6 months. Postoperative reflux symptoms developed in 5%
(1/19) of the thoracoscopy group and 8% (4/39) of the laparoscopy
group. Nine patients have persistent or recurrent dysphagia (16%).
Seven patients have successfully undergone Savary dilation, and 2
required esophagectomy to manage recalcitrant dysphagia. Conclusion:
At this intermediate term analysis, video-assisted approaches for man-
agement of achalasia are a reasonable alternative to extended medi-
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minimally invasive thoracic surgical techniques and
with the increasing acceptance of laparoscopic antire-
flux procedures, we explored the utility of these mini-
mally invasive surgical approaches in the treatment of
esophageal achalasia.
Patients and methods
Patient profile. Over a 73-month period between
December 1991 and January 1998, 58 patients with
esophageal achalasia underwent minimally invasive
esophagomyotomy. During this period, open myotomies were
performed on 17 patients. The mean age of the 58 patients
was 47.2 years and there were 32 women and 26 men. The
clinical evaluation consisted of a history and physical exami-
nation, barium esophagogram, esophagoscopy, and esopha-
geal manometry. Prolonged esophageal pH testing to rule out
associated gastroesophageal reflux disease was only rarely
performed because of the inherent lack of indication/utility
associated with this technique in the preoperative assessment
of esophageal achalasia. Nineteen patients underwent thora-
coscopic esophagomyotomy and 39 patients underwent a
laparoscopic esophagomyotomy and a partial fundoplication
procedure. The decision to use either a laparoscopic or thora-
coscopic approach was based on the surgeon’s preference for
and experience with either the thoracoscopic or laparoscopic
techniques. Of the antireflux procedures used in conjunction
with the laparoscopic esophagomyotomies, an anterior partial
fundoplication (Dor) was performed in 15 patients and a pos-
terior partial fundoplication (Toupet) in 24 patients.7,8
Clinical features. The diagnosis of achalasia was made by
assessing the combined results of the patient’s clinical history,
esophagogastroduodenoscopy, barium esophagogram, and
esophageal manometry. All 58 patients had preoperative dys-
phagia and 45 (78%) of the 58 patients described important
regurgitation symptoms. Weight loss greater than 10 pounds
was noted in 29 patients (47%). Respiratory complications
were also common (aspiration, recurrent pneumonia, bron-
chitis), occurring in 13 patients (22%). Postprandial chest
pain was an important primary symptom described by 21
patients (36%), and 35 patients (60%) had a sensation of
heartburn. Interestingly, this heartburn sensation was poorly
relieved with antacid or antisecretory therapy. The average
duration of symptoms was 59.9 ± 56.5 months with a range
of 3 to 240 months. Barium esophagograms demonstrated an
average esophageal body diameter of 6 cm, and important
tortuosity in the body of the esophagus was noted in 9 (16%)
of the 58 patients. Manometric studies demonstrated an aver-
age lower esophageal sphincter pressure of 31.5 ± 14.9 mm
Hg. A lack of peristaltic contraction and the absence of lower
esophageal sphincter relaxation in response to swallowing
was uniformly noted. Sixty-six percent of patients had absent
or very poor esophageal body contractility identified at
esophageal manometric assessment. Forty-seven patients
(81%) had undergone at least 1 previous pneumatic dilation
and 8 patients (14%) had previously received botulinum toxin
administration. One patient had undergone a previous open
transthoracic myotomy 12 years earlier.
Surgical approaches
Laparoscopic approach. After careful induction of general
anesthesia particularly aimed at avoiding aspiration,
Fig 1. Line drawing of sites of abdominal trocar access.
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esophagoscopy is performed to remove any residual debris
within the esophagus and to inspect the distal esophagus and
rule out any other pathologic condition that may be mimick-
ing achalasia (ie, pseudoachalasia caused by a malignant
tumor or peptic stricture). The esophagoscope is left in place
during the procedure to provide transillumination of the
esophageal wall and periodic insufflation during the proce-
dure to ensure the adequacy of the esophagomyotomy.
The trocar access used to accomplish the laparoscopic
myotomy is arranged in 2 horizontal rows across the
abdomen (Fig 1).
Our approach to the hiatal dissection is nearly the same as
that performed through an open laparotomy. The gastric fat
pad at the cardia of the stomach is grasped to put tension on
the phrenoesophageal membrane over the distal esophagus.
The lesser omentum of the gastrohepatic ligament is incised
from the phrenoesophageal membrane superiorly to the arcu-
ate ligament inferiorly. This incision exposes the right crural
margin and the peritoneal envelope over the distal esophagus.
This peritoneum is incised from the arcuate ligament inferi-
orly to the upper lateral aspect of the right crural arch. The
distal esophagus is exposed in the lower part of the medi-
astinum and further dissection is then carried out in the pos-
terior part of the mediastinum so as to identify and preserve
the posterior vagal nerve trunk and to establish the posterior
tunnel for subsequent mobilization of the gastric fundus for
partial fundoplication.7,8
After the dissection of the right aspect of the distal esoph-
agus is completed, the phrenoesophageal membrane over
the left aspect of the distal esophagus is divided, including
the upper gastrosplenic membranous attachments superior
to the short gastric vessels. The left crus and the left lateral
aspect of the distal esophagus are thereby exposed. The short
gastric vessels along the greater curvature of the stomach are
divided with the Harmonic Scalpel device (Ethicon Endo-
Surgery, Inc, Cincinnati, Ohio) to the level of the left crus.
This results in complete mobilization of the gastric fundus.
The esophagoscope is positioned under direct endoscopic
vision to the level of the gastroesophageal junction. The
esophagoscope is easily identified as the lighted tip transillu-
minates through the wall of the esophagus. We insufflate the
lumen of the esophagus slightly to further assist in delineat-
ing the location of the obstruction at the gastroesophageal
junction.
The esophagomyotomy is begun on the distal esophagus
approximately 2 cm above the gastroesophageal junction
(Figs 2 and 3). Sharp dissection with the endoscopic scissors
is augmented with monopolar electrocautery attached to this
instrument. Once the mucosal layer is reached, the dissection
is carried inferiorly and superiorly on the esophagus within
this avascular plane. Periodic insufflation of the esophago-
scope ensures that the mucosal layer is intact and that the
dissections are proceeding in the proper plane. The
esophagomyotomy is extended on the cardia of the stomach
until the transverse venous plexus of the cardia is encoun-
tered. Simultaneous viewing of the lumen of the esophagus
through the esophagoscope allows us to judge when the
myotomy has been completed, as the rosette of mucosa that
is seen at the distal esophageal obstruction becomes obliter-
ated and free entry of the esophagoscope into the stomach is
Fig 2. Line drawing of esophageal achalasia and line of pro-
posed esophagomyotomy.
Fig 3. Line drawing of laparoscopic myotomy in progress.
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achieved. The myotomy is then widened by teasing the
esophageal musculature from the mucosa to ensure that
approximately 50% of the mucosal surface has been
unroofed. As mentioned, the proximal extent of the myotomy
is to the inferior pulmonary ligament as viewed through the
diaphragmatic hiatus.
Once the myotomy has been completed, a modified poste-
rior or anterior partial fundoplication is created (Fig 4). 
Thoracoscopic myotomy approach. Our thoracoscopic
esophagomyotomy is similar to that described by others.9
Contralateral single lung ventilation is accomplished with
double-lumen endotracheal intubation to allow for ipsilateral
lung collapse and optimal visualization of the esophagus and
posterior mediastinal structures. The patient is positioned in
the right lateral decubitus position. The basic concepts of tho-
racoscopic techniques are used.10
Intercostal access consists of 4 to 5 sites placed in 2 nearly
parallel vertical rows. The anterior row is aligned along the
anterior axillary line. The second row of intercostal access is
aligned along a midaxillary to slightly posterior axillary line.
The fiberoptic esophagoscope is left in place during the
myotomy procedure to assist in elevating the esophagus out
of the posterior mediastinal bed and for transillumination and
periodic insufflation of the esophageal lumen during the
myotomy to ensure the integrity of the mucosa and the ade-
quacy of the myotomy. The myotomy is begun at or slightly
above the level of the inferior pulmonary ligament. It is
extended on the distal esophagus to beyond the phreno-
esophageal membrane so as to enter the coelomic cavity. We
extend the esophagomyotomy on the cardia of the stomach to
the level of the transverse venous plexus of this region of the
stomach. We take care to avoid injury to the more distal
oblique muscular sling fibers whose integrity is important in
preserving competency of the antireflux mechanism. An
antireflux procedure is not included with the myotomy when
the thoracoscopic approach is used.9,11,12
Follow-up. Routine follow-up evaluation occurred in the
early postoperative period (within 30 days of hospital dis-
charge), 6 months after the operation, and then on an annual
basis. At the return visits, symptoms were graded with regard
to regurgitation, dysphagia, heartburn, chest pain, gas bloat,
and diarrhea by means of a symptom analog scale ranging
from 0 to 10. In addition, patients were asked to grade their
“lifestyle change” and “overall sense of well-being” relative
to their preoperative status using a similar 0-to-10 visual ana-
log scale. These scores at 1 month, 6 months, and annually
were compared with the patients’ preoperative symptoms. A
postoperative symptom score similar to the system described
by Jamieson and Duranceau13 was also used to characterize
the patients’ symptoms before and after repair of achalasia
(Table I). In this scoring system, the frequency of symptoms
is added to the duration of symptoms and the sum is multi-
plied by the severity of symptoms. A minimum score of 0 and
a maximum score of 32 is possible. Symptom classification is
as follows: mild (1-7), moderate (8-15), marked (16-23), and
severe (24-32). The percent change from the patients’ preop-
erative scores was calculated. In addition to these symptom
assessments, follow-up contrast esophagograms were
obtained in 30 (52%) of the 58 patients, and follow-up
manometry and pH testing were performed in 10 (17%) of
the 58 patients.
Statistical methods. Data were collected by study coordi-
nators, entered into a computerized information management
system, and after cleaning and accuracy checks, subjected to
analysis. Analysis was conducted with SAS software (SAS
Institute, Inc, Cary, NC) on personal computers. The design
is an extension of the pretest-posttest design to a preopera-
tive-postoperative situation with 2 time points (eg, preopera-
tive and 6 months, preoperative and 1 year, and preoperative
and 2 years). The data in each paired analysis were analyzed
by means of a paired t test to determine changes in symptom
scores for each symptom among each of the 3 postoperative
evaluation periods. In addition, a Bonferroni adjustment was
made to control for inflation of type 1 error. A P value of
.0056 was set as the adjusted level for statistical significance.
Each paired analysis was evaluated for departures from nor-
mal before analysis. In all cases, data met minimal require-
ments for parametric analysis.
Results
The average operative time was 183.2 minutes (tho-
racoscopy, 137 ± 41 minutes; laparoscopy, 206 ± 52
minutes; P = .04). This difference was primarily relat-
ed to the time required to accomplish the fundoplica-
tion procedure after the laparoscopic esophagomyoto-
my. The average length of postoperative stay was 2.3 ±
0.8 days. The difference in the length of postoperative
Fig 4. Line drawing of completed Toupet fundoplication.
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stay between patients undergoing thoracoscopic or
laparoscopic procedures was not statistically signifi-
cant. Intraoperative esophageal perforation occurred in
1 patient undergoing thoracoscopy. This perforation
was repaired thoracoscopically without sequelae. There
were no postoperative deaths.
All patients described marked improvement or reso-
lution of their dysphagia symptoms after the operation.
Table II shows the symptom score based on a 0-to-10
scale on a variety of symptoms and lifestyle issues
associated with achalasia. Chest pain, regurgitation,
and dysphagia significantly improved after the opera-
tion, and diarrhea and gas bloat were unchanged.
Overall sense of well-being and the overall symptom
score13 were significantly improved after the operation.
The changes in symptoms, lifestyle, sense of well-
being, and overall symptom scores were statistically
significant, as noted in Table II. Similarly, these
changes were significantly different at various times
analyzed postoperatively with dysphagia and regurgita-
tion being statistically significant throughout the peri-
od of follow-up. According to the symptom score
described by Jamieson and Duranceau,13 our patients’
symptoms at 6 months, 1 year, and 2 years were signif-
icantly better than before the operation. Patients also
described a significant improvement in their
“lifestyles” and believed their overall “sense of well-
being” was significantly better than before the opera-
tion. Six of the 46 patients with preoperative regurgita-
tion had persistent postoperative regurgitation. Three
patients had persistent chest pain after the operation.
At the 6-month follow-up point, 30 (52%) of the 58
patients had a postoperative barium esophagogram.
The mean esophageal diameter was reduced to 4.6 ±
1.8 cm from a preoperative value of 6.2 ± 1.6 cm (P =
.0001). Ten patients had postoperative manometry per-
formed 6 months after the operation. The lower
esophageal sphincter pressure had decreased signifi-
cantly from 31.5 ± 14.9 mm Hg to 13.5 ± 3.4 mm Hg.
The improvement in preoperative symptoms and radio-
Table I. Achalasia symptom scoring method
0 Points 1 Point 2 Points 3 Points 4 Points
I. Frequency None Occasional: Not as often More often than More often than Daily
as once a month once a month but once a week but 
not as often as not as often as 
once a week once a day
II. Duration No symptoms Less than 6 months More than 6 months More than 24 More than 60 
but less than 24 months but less than months
months 60 months
III. Severity Absent Mild: Nuisance value Moderate: Spoils Marked: Interferes with Severe: Worst thing 
only enjoyment of life living a normal life ever experienced
Calculations: Add frequency to duration and multiply by severity: minimum score = 0; maximum score = 32. (From Jamieson GG, Duranceau AC. The investigation
and classification of reflux disease. In: Jamieson GG, editor. Surgery of the oesophagus. New York: Churchill Livingstone; 1988. p. 201.)
Table II. Mean change in symptoms between baseline and 6 months, 1 year, and 2 years
Baseline and 6 months Baseline and 1 year Baseline and 2 years
Mean No. of Mean No. of Mean No. of 
change cases P value change cases P value change cases P value
Heartburn –4.5 44 .0001 –7.3 20 .0001 –6.3 26 .0001
Regurgitation –6.4 44 .0001 –7.1 20 .0001 –7.1 15 .0001
Dysphagia –8.0 44 .0001 –6.3 20 .0001 –6.7 15 .0001
Gas bloats –0.15 44 .73 –0.89 19 .23 –0.75 16 .21
Diarrhea –0.67 52 .002 –0.69 23 .12 –1.2 22 .002
Chest pain –3.6 44 .0001 –4.9 21 .0001 –2.2 16 .06
Lifestyle 0.42 57 .001 0.32 28 .35 0.76 21 .09
Well-being 2.3 52 .0001 3.0 33 .0001 3.6 31 .0001
Score* –21.8 44 .0001 –24.2 19 .0001 –19.1 16 .0001
Observations limited to those individuals evaluated at both time points. In all cases, the second score was subtracted from the baseline (eg, baseline – 6 month score).
Calculations based on a formula provided in Jamieson GG, Duranceau AC. The investigation and classification of reflux disease. In: Jamieson GG, editor. Surgery
of the oesophagus. New York: Churchill Livingstone; 1988. p. 201.
*See Table I.
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graphic/manometric findings was similar between the
laparoscopy and thoracoscopy groups, although 6 of
the 7 patients requiring postoperative esophageal dila-
tion had a thoracoscopic myotomy performed.
Nine (16%) of the 58 patients described recurrence of
dysphagia during the period of follow-up. Seven of the
9 patients with significant postoperative dysphagia were
managed effectively with 1 or multiple bougie dilations
(range 1-4). Two patients had severe recurrent dyspha-
gia that was not amenable to dilation therapy. These 2
patients underwent a transhiatal esophagectomy 4 and 7
months after their minimally invasive myotomy.
Comments
Primary treatment options for esophageal achalasia
include pneumatic dilation, botulinum toxin injection,
and esophagomyotomy.14-17 Although controversy
exists regarding the “optimal” choice of initial treat-
ment, many patients will eventually require surgical
management of their disease.16,18
The excellent intermediate term results, minimal
postoperative pain, and the early recovery from the
laparoscopic antireflux operation for medically refrac-
tory gastroesophageal reflux disease has changed the
attitude of many patients and referring physicians
regarding the primary surgical management of esopha-
geal disorders, including gastroesophageal reflux dis-
ease and paraesophageal hiatal hernias.19-21 A similar
inclination has arisen regarding the use of minimally
invasive thoracic surgical approaches for a wide variety
of thoracic surgical problems, including esophageal
achalasia. The improvements in the primary symptoms
in our patients undergoing either laparoscopic or thora-
coscopic approaches for achalasia confirm the findings
of other investigators exploring these techniques.22
Excellent control of dysphagia symptoms (96%) was
noted in both thoracoscopic/laparoscopic esophagomy-
otomy cohorts. The results further confirm a favorable
outcome with these minimally invasive surgical
approaches that compares well against that seen for
endoscopic pneumatic balloon therapy.
Despite the excellent initial improvement in dyspha-
gia and symptom scores, 9 patients followed up
between 8 and 72 months after the operation required
esophageal dilation for symptoms of recurrent dyspha-
gia. Seven of the 9 patients have had sustained
improvement in their dysphagia with dilation alone.
Two patients have required esophagectomy for recur-
rent symptoms refractory to intermittent dilation thera-
py. Late recurrence of dysphagia reinforces the need for
long-term follow-up of these patients.14,23 The fact that
most patients with postoperative dysphagia requiring
dilation had undergone a thoracoscopic myotomy may
reflect a difficulty in performing an adequate distal
myotomy by means of this technique. Only 1 patient
who had a laparoscopic myotomy required postopera-
tive dilation for recurrent dysphagia.
Subjective reflux symptoms after these minimally
invasive approaches were infrequent, occurring in only 6
(10%) of the 58 patients. These acceptable results reflect
our approach of routinely performing an antireflux pro-
cedure in patients undergoing a laparoscopic procedure
and sparing the upper gastric sling fibers and most of the
lateral phrenoesophageal attachments when performing
thoracoscopic interventions. No difference was noted in
postoperative reflux symptoms between patients under-
going thoracoscopic or laparoscopic procedures.
These minimally invasive procedures were primarily
used to manage early to moderate disease or uncompli-
cated achalasia. Both of the patients requiring later
esophagectomy in our series had significant esophageal
dilatation and esophageal redundancy recognized in the
preoperative period. The role of minimally invasive sur-
gical management of patients with megaesophagus is not
as yet determined. Patients with advanced achalasia may
be better managed with primary esophageal resection.
As these minimally invasive approaches become
more accepted in the management of esophageal disor-
ders, the thoracic surgeons disengaged from these
approaches may be left out of the management of these
conditions with which they had historically been
involved. Although the technical demands of these
minimally invasive surgical approaches are similar to
those of open surgical esophagomyotomy, it appears
that these thoracoscopic techniques are a safe and
effective alternative to open operations for the manage-
ment of uncomplicated esophageal achalasia.
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Discussion
Dr Antoon E. M. R. Lerut (Leuven, Belgium). From this
presentation it becomes clear that minimally invasive treatment
of achalasia is technically feasible with minimal operative and
postoperative complications and without postoperative mortal-
ity. I therefore fully endorse your conclusions that thoracic sur-
geons interested in esophageal disease should become familiar
with these techniques. I have some remarks on your conclusion
of an overall improvement of primary symptoms in up to 97%
of the patients at 6 months’ evaluation.
To come to this conclusion you have been using a visual
analog scale to score the different symptoms and then incor-
porating these scores in the Jamieson-Duranceau scoring sys-
tem by adding frequency and duration of symptoms.
However, a substantial subset of your patients has not yet
reached 2 years’ follow-up, which means that these patients
cannot reach the 3- or 4-point mark in the duration of symp-
toms score. To a certain extent, this influences the final result
in a favorable way. Indeed, at 2 years only a maximum score
of 24 points can be reached against a maximum of 32 points
before the operation, as the mean duration of symptoms was
as much as 60 months. Moreover, as such a scoring system
deals with the overall results from the entire group of
patients, it acts like a smoke screen disguising the scores of
each individual patient, which I think are much more relevant
to evaluate. In fact, 6 patients continue to have regurgitation,
5 have symptoms suggesting reflux, and 3 continue to have
chest pain. Furthermore, you mentioned 23 patients with
postoperative loss of weight, with a mean of 5 kg, and as
many as 9 patients (15%) required subsequent dilations, 2 of
whom eventually had an esophagectomy. In my mind the true
failure rate of the cardinal symptom, dysphagia, is 15%, illus-
trating a tendency of gradual degradation of the results over
time. 
Also troublesome is the lack of objective evaluation. Only
68% had a preoperative documented manometric diagnosis,
and in the postoperative evaluation there were only 10
manometries and 24 pH studies, with no repeat on the results
of the latter investigation. Therefore I think your conclusion
is overly optimistic. Further careful follow-up is certainly
required to evaluate whether this method really matches the
results obtained in open operations.
I have 3 questions. First, this is a multi-institutional report
dealing with 58 patients spread out over 5 institutions over 70
months. That means mathematically about 2 cases a year by
each center. I would like to hear your comments about the
problems of learning curves and how to avoid the pitfalls of
such learning curves.
Second, what is supposed to be the cause of recurrent dys-
phagia? Was there any difference between the thoracoscopic
and laparoscopic approaches, the Toupet or the Dor anti-
platelet procedure, or in patients who had previous pneumat-
ic dilations? Why did you not perform a second myotomy
rather than an esophagectomy, unless the esophagectomy was
already indicated at the first operation? 
Third, did you find any morphologic differences in those
patients who had previous pneumatic dilations and/or the
number of those dilations? Is the operation more difficult in
those patients? In other words, does pneumatic dilation unfa-
vorably affect the indication for minimally invasive
approaches? This eventually would be an argument favoring
surgery over pneumatic dilation.
Dr Wiechmann. I agree that careful follow-up is certainly
necessary in this group of patients. In response to your ques-
tions, I think there is a learning curve. In fact, our numbers at
all institutions increased significantly with time, and there
was clearly a progression of the procedure with time. As to
avoiding pitfalls of the learning curve, as we become more
experienced with all laparoscopic and thoracoscopic tech-
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niques, then we are able to avoid the pitfalls of this procedure.
It is essential to understand the pathophysiology of achalasia
and to be accomplished in the open management of this dis-
ease process before one begins to use minimally invasive
techniques. 
Was there a difference in dysphagia between the patients
who underwent a thoracoscopic or a laparoscopic approach?
We compared the patients who had undergone a thoraco-
scopic and laparoscopic approach with this question in mind
and did not find a significant difference in postoperative dys-
phagia. There was a slight difference in operative time but no
significant difference in efficacy of the procedure. The 2
(13%) patients who underwent an esophagectomy had rather
advanced disease with significant tortuosity and more of a
“sink trap esophagus.” Our experience with these 2 patients
led us to the conclusion that this procedure would be better
attempted in patients with uncomplicated achalasia and
without significant tortuosity. In fact, 2 patients who had sig-
nificant tortuosity and underwent a minimally invasive pro-
cedure did later require esophagectomy because of failure of
the procedure. 
Was there a difference in patients who had preoperative
dilations? Most of our patients did undergo preoperative dila-
tion, and I do not believe surgery was more difficult in those
who had undergone dilation and those that had not. Therefore
I do not believe that patients who undergo preoperative dila-
tion should be excluded from undergoing a minimally invasive
procedure, nor are their operations significantly more difficult.
Timely
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